A prospective study of grey matter and cognitive function alterations in chemotherapy-treated breast cancer patients.
about
Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in MiceCytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction.Recovery from chemotherapy-induced white matter changes in young breast cancer survivors?Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors.TFEB ameliorates the impairment of the autophagy-lysosome pathway in neurons induced by doxorubicin.The attention network changes in breast cancer patients receiving neoadjuvant chemotherapy: Evidence from an arterial spin labeling perfusion study.Disrupted brain network functional dynamics and hyper-correlation of structural and functional connectome topology in patients with breast cancer prior to treatment.Subtle hippocampal deformities in breast cancer survivors with reduced episodic memory and self-reported cognitive concerns.A systemic literature review of neuroimaging studies in women with breast cancer treated with adjuvant chemotherapy.Predicting Long-Term Cognitive Outcome Following Breast Cancer with Pre-Treatment Resting State fMRI and Random Forest Machine Learning.Changes in cognition and dendritic complexity following intrathecal methotrexate and cytarabine treatment in a juvenile murine model.Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment.Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study.Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer
P2860
Q28551025-92F5928C-4C80-4217-A3D4-F2C0A1201763Q30390049-8600F4AE-67A3-4D59-ACDE-88E05E8C20D1Q31155370-CD3CADB2-0AFB-4E0A-93FF-F4BAD00E0A27Q34503992-9C7CBDA1-1263-4E94-B45A-EA82FEE9FC13Q37610214-C9FA0006-34D1-4D4F-9832-3A0B95934FCBQ37648505-7BCDB9DE-5763-49DB-94D3-D8CB7D949129Q37694398-B877DCB4-6774-4D67-AD6F-5A1F9F350A7EQ37725264-29B4F5B1-87F1-406B-A693-E3709F6B2E45Q37743138-51F9B9F0-CE46-4354-AAFA-D49B3A6C6298Q45943432-F2B7E2A8-30E5-4E24-9C6D-8BC6CB276584Q47327834-6C0C2142-71AA-418D-8255-C26DF9C6C639Q48706983-D99DFCD3-58EF-4DA4-BC66-360A33650210Q55184471-1328393D-B6C8-4AED-ADA4-283BE1A82899Q57170361-D65DB653-D618-40ED-9C42-B30107182E72
P2860
A prospective study of grey matter and cognitive function alterations in chemotherapy-treated breast cancer patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A prospective study of grey ma ...... reated breast cancer patients.
@ast
A prospective study of grey ma ...... reated breast cancer patients.
@en
A prospective study of grey ma ...... reated breast cancer patients.
@nl
type
label
A prospective study of grey ma ...... reated breast cancer patients.
@ast
A prospective study of grey ma ...... reated breast cancer patients.
@en
A prospective study of grey ma ...... reated breast cancer patients.
@nl
prefLabel
A prospective study of grey ma ...... reated breast cancer patients.
@ast
A prospective study of grey ma ...... reated breast cancer patients.
@en
A prospective study of grey ma ...... reated breast cancer patients.
@nl
P2093
P2860
P356
P1433
P1476
A prospective study of grey ma ...... treated breast cancer patients
@en
P2093
Andra M Smith
Barbara Collins
Carole Scherling
Emily Barlow-Krelina
Jeremy Moreau
Joyce MacKenzie
Nancy Wallis
P2860
P2888
P356
10.1186/2193-1801-3-444
P50
P577
2014-08-19T00:00:00Z
P5875
P6179
1045300797